keyword
https://read.qxmd.com/read/38748818/relationships-between-bitter-taste-receptor-gene-evolution-diet-and-gene-repertoire-in-primates
#21
JOURNAL ARTICLE
Ping Feng, Hui Wang, Xinyue Liang, Xiaoyan Dong, Qiufang Liang, Fanglan Shu, Qihai Zhou
Bitter taste perception plays a critical role in deterring animals from consuming harmful and toxic substances. To characterize the evolution of primate Tas2r, test the generality of Tas2r duplication in Cercopithecidae species, and examine whether dietary preferences have shaped the Tas2r repertoire of primate species, we identified Tas2r in the genomes of 35 primate species, including 16 Cercopithecidae, 6 Hominidae, 4 Cebidae, 3 Lemuridae, and 6 other species. The results showed that the total number of primate Tas2r ranged from 27 to 51, concentrating on 2-4 scaffolds of each species...
May 15, 2024: Genome Biology and Evolution
https://read.qxmd.com/read/38746379/sustained-inactivation-of-the-polycomb-prc1-complex-induces-dna-repair-defects-and-genomic-instability-in-epigenetic-tumors
#22
Chetan C Rawal, Vincent Loubiere, Nadejda L Butova, Juliette Garcia, Victoria Parreno, Anne-Marie Martinez, Giacomo Cavalli, Irene Chiolo
Cancer initiation and progression are typically associated with the accumulation of driver mutations and genomic instability. However, recent studies demonstrated that cancers can also be purely initiated by epigenetic alterations, without driver mutations. Specifically, a 24-hours transient down-regulation of polyhomeotic (ph-KD), a core component of the Polycomb complex PRC1, is sufficient to drive epigenetically initiated cancers (EICs) in Drosophila, which are proficient in DNA repair and are characterized by a stable genome...
April 24, 2024: Research Square
https://read.qxmd.com/read/38746331/non-hypermutator-cancers-access-driver-mutations-through-reversals-in-germline-mutational-bias
#23
Marwa Z Tuffaha, David Castellano, Claudia Serrano Colome, Ryan N Gutenkunst, Lindi M Wahl
Cancer is an evolutionary disease driven by mutations in asexually-reproducing somatic cells. In asexual microbes, bias reversals in the mutation spectrum can speed adaptation by increasing access to previously undersampled beneficial mutations. By analyzing tumors from 20 tissues, along with normal tissue and the germline, we demonstrate this effect in cancer. Non-hypermutated tumors reverse the germline mutation bias and have consistent spectra across tissues. These spectra changes carry the signature of hypoxia, and they facilitate positive selection in cancer genes...
May 3, 2024: bioRxiv
https://read.qxmd.com/read/38746115/targeting-circadian-transcriptional-programs-in-triple-negative-breast-cancer-through-a-cis-regulatory-mechanism
#24
Yuanzhong Pan, Tsu-Pei Chiu, Lili Zhou, Priscilla Chan, Tia Tyrsett Kuo, Francesca Battaglin, Shivani Soni, Priya Jayachandra, Jingyi Jessica Li, Heinz-Josef Lenz, Shannon M Mumenthaler, Remo Rohs, Evanthia Roussos Torres, Steve A Kay
Circadian clock genes are emerging targets in many types of cancer, but their mechanistic contributions to tumor progression are still largely unknown. This makes it challenging to stratify patient populations and develop corresponding treatments. In this work, we show that in breast cancer, the disrupted expression of circadian genes has the potential to serve as biomarkers. We also show that the master circadian transcription factors (TFs) BMAL1 and CLOCK are required for the proliferation of metastatic mesenchymal stem-like (mMSL) triple-negative breast cancer (TNBC) cells...
April 29, 2024: bioRxiv
https://read.qxmd.com/read/38745155/fgfr2-triggered-autophagy-and-activation-of-nrf-2-reduce-breast-cancer-cell-response-to-anti-er-drugs
#25
JOURNAL ARTICLE
Monika Gorska-Arcisz, Marta Popeda, Marcin Braun, Dominika Piasecka, Joanna I Nowak, Kamila Kitowska, Grzegorz Stasilojc, Marcin Okroj, Hanna M Romanska, Rafal Sadej
BACKGROUND: Genetic abnormalities in the FGFR signalling occur in 40% of breast cancer (BCa) patients resistant to anti-ER therapy, which emphasizes the potential of FGFR-targeting strategies. Recent findings indicate that not only mutated FGFR is a driver of tumour progression but co-mutational landscapes and other markers should be also investigated. Autophagy has been recognized as one of the major mechanisms underlying the role of tumour microenvironment in promotion of cancer cell survival, and resistance to anti-ER drugs...
May 14, 2024: Cellular & Molecular Biology Letters
https://read.qxmd.com/read/38745009/trastuzumab-deruxtecan-in-her2-positive-advanced-gastric-cancer-exploratory-biomarker-analysis-of-the-randomized-phase-2-destiny-gastric01-trial
#26
JOURNAL ARTICLE
Kohei Shitara, Yung-Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min-Hee Ryu, Daisuke Sakai, Hyun Cheol Chung, Hisato Kawakami, Hiroshi Yabusaki, Yasuhiro Sakamoto, Tomohiro Nishina, Koichiro Inaki, Yusuke Kuwahara, Naoya Wada, Fumitaka Suto, Takeo Arita, Masahiro Sugihara, Zenta Tsuchihashi, Kaku Saito, Akihito Kojima, Kensei Yamaguchi
Trastuzumab deruxtecan (T-DXd) showed statistically significant clinical improvement in patients with human epidermal growth factor receptor 2-positive (HER2+ ) gastric cancer in the DESTINY-Gastric01 trial. Exploratory results from DESTINY-Gastric01 suggested a potential benefit in patients with HER2-low gastric cancer. Spatial and temporal heterogeneity in HER2 expression or gene alteration, an inherent characteristic of gastric cancer tumors, presents a challenge in identifying patients who may respond to T-DXd...
May 14, 2024: Nature Medicine
https://read.qxmd.com/read/38744975/analysis-of-somatic-mutations-in-whole-blood-from-200-618-individuals-identifies-pervasive-positive-selection-and-novel-drivers-of-clonal-hematopoiesis
#27
JOURNAL ARTICLE
Nicholas Bernstein, Michael Spencer Chapman, Kudzai Nyamondo, Zhenghao Chen, Nicholas Williams, Emily Mitchell, Peter J Campbell, Robert L Cohen, Jyoti Nangalia
Human aging is marked by the emergence of a tapestry of clonal expansions in dividing tissues, particularly evident in blood as clonal hematopoiesis (CH). CH, linked to cancer risk and aging-related phenotypes, often stems from somatic mutations in a set of established genes. However, the majority of clones lack known drivers. Here we infer gene-level positive selection in whole blood exomes from 200,618 individuals in UK Biobank. We identify 17 additional genes, ZBTB33, ZNF318, ZNF234, SPRED2, SH2B3, SRCAP, SIK3, SRSF1, CHEK2, CCDC115, CCL22, BAX, YLPM1, MYD88, MTA2, MAGEC3 and IGLL5, under positive selection at a population level, and validate this selection pattern in 10,837 whole genomes from single-cell-derived hematopoietic colonies...
May 14, 2024: Nature Genetics
https://read.qxmd.com/read/38744952/exploring-the-prognostic-significance-of-arm-level-copy-number-alterations-in-triple-negative-breast-cancer
#28
JOURNAL ARTICLE
Samuel Doré, Mariam Ali, Mark Sorin, Sheri A C McDowell, Lysanne Desharnais, Valérie Breton, Miranda W Yu, Azadeh Arabzadeh, Malcolm I Ryan, Simon Milette, Daniela F Quail, Logan A Walsh
Somatic copy number alterations (SCNAs) are prevalent in cancer and play a significant role in both tumorigenesis and therapeutic resistance. While focal SCNAs have been extensively studied, the impact of larger arm-level SCNAs remains poorly understood. Here, we investigated the association between arm-level SCNAs and overall survival in triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer lacking targeted therapies. We identified frequent arm-level SCNAs, including 21q gain and 7p gain, which correlated with poor overall survival in TNBC patients...
May 14, 2024: Oncogene
https://read.qxmd.com/read/38744814/disentangling-oncogenic-amplicons-in-esophageal-adenocarcinoma
#29
JOURNAL ARTICLE
Alvin Wei Tian Ng, Dylan Peter McClurg, Ben Wesley, Shahriar A Zamani, Emily Black, Ahmad Miremadi, Olivier Giger, Rogier Ten Hoopen, Ginny Devonshire, Aisling M Redmond, Nicola Grehan, Sriganesh Jammula, Adrienn Blasko, Xiaodun Li, Samuel Aparicio, Simon Tavaré, Karol Nowicki-Osuch, Rebecca C Fitzgerald
Esophageal adenocarcinoma is a prominent example of cancer characterized by frequent amplifications in oncogenes. However, the mechanisms leading to amplicons that involve breakage-fusion-bridge cycles and extrachromosomal DNA are poorly understood. Here, we use 710 esophageal adenocarcinoma cases with matched samples and patient-derived organoids to disentangle complex amplicons and their associated mechanisms. Short-read sequencing identifies ERBB2, MYC, MDM2, and HMGA2 as the most frequent oncogenes amplified in extrachromosomal DNAs...
May 14, 2024: Nature Communications
https://read.qxmd.com/read/38744099/an-investigation-of-the-clinical-impact-and-therapeutic-relevance-of-a-dna-damage-immune-response-ddir-signature-in-patients-with-advanced-gastroesophageal-adenocarcinoma
#30
JOURNAL ARTICLE
M A Baxter, L C Spender, D Cairns, S Walsh, R Oparka, R J Porter, S Bray, G Skinner, S King, J Turbitt, D Collinson, Z H Miedzybrodzka, G Jellema, G Logan, R D Kennedy, R C Turkington, M H McLean, D Swinson, H I Grabsch, S Lord, M J Seymour, P S Hall, R D Petty
BACKGROUND: An improved understanding of which gastroesophageal adenocarcinoma (GOA) patients respond to both chemotherapy and immune checkpoint inhibitors (ICI) is needed. We investigated the predictive role and underlying biology of a 44-gene DNA damage immune response (DDIR) signature in patients with advanced GOA. MATERIALS AND METHODS: Transcriptional profiling was carried out on pretreatment tissue from 252 GOA patients treated with platinum-based chemotherapy (three dose levels) within the randomized phase III GO2 trial...
May 13, 2024: ESMO Open
https://read.qxmd.com/read/38744009/cancergate-prediction-of-cancer-driver-genes-using-graph-attention-autoencoders
#31
JOURNAL ARTICLE
Seunghwan Jung, Seunghyun Wang, Doheon Lee
Discovery of the cancer type specific-driver genes is important for understanding the molecular mechanisms of each cancer type and for providing proper treatment. Recently, graph deep learning methods became widely used in finding cancer-driver genes. However, previous methods had limited performance in individual cancer types due to a small number of cancer-driver genes used in training and biases toward the cancer-driver genes used in training the models. Here, we introduce a novel pipeline, CancerGATE that predicts the cancer-driver genes using graph attention autoencoder (GATE) to learn in a self-supervised manner and can be applied to each of the cancer types...
May 9, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38742521/ferreg-ferroptosis-based-regulation-of-disease-occurrence-progression-and-therapeutic-response
#32
JOURNAL ARTICLE
Yuan Zhou, Zhen Chen, Mengjie Yang, Fengyun Chen, Jiayi Yin, Yintao Zhang, Xuheng Zhou, Xiuna Sun, Ziheng Ni, Lu Chen, Qun Lv, Feng Zhu, Shuiping Liu
Ferroptosis is a non-apoptotic, iron-dependent regulatory form of cell death characterized by the accumulation of intracellular reactive oxygen species. In recent years, a large and growing body of literature has investigated ferroptosis. Since ferroptosis is associated with various physiological activities and regulated by a variety of cellular metabolism and mitochondrial activity, ferroptosis has been closely related to the occurrence and development of many diseases, including cancer, aging, neurodegenerative diseases, ischemia-reperfusion injury and other pathological cell death...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38742185/effects-of-landscape-resource-use-and-body-size-on-genetic-structure-in-bee-populations
#33
JOURNAL ARTICLE
Melissa Hernandez, Sevan Suni
Quantifying genetic structure and levels of genetic variation are fundamentally important to predicting the ability of populations to persist in human-altered landscapes and adapt to future environmental changes. Genetic structure reflects the dispersal of individuals over generations, which can be mediated by species-level traits or environmental factors. Dispersal distances are commonly positively associated with body size and negatively associated with the amount of degraded habitat between sites, motivating the investigation of these potential drivers of dispersal concomitantly...
May 2024: Ecology and Evolution
https://read.qxmd.com/read/38741120/incidences-of-colorectal-adenomas-and-cancers-under-colonoscopy-surveillance-suggest-an-accelerated-big-bang-pathway-to-crc-in-three-of-the-four-lynch-syndromes
#34
JOURNAL ARTICLE
Pål Møller, Saskia Haupt, Aysel Ahadova, Matthias Kloor, Julian R Sampson, Lone Sunde, Toni Seppälä, John Burn, Inge Bernstein, Gabriel Capella, D Gareth Evans, Annika Lindblom, Ingrid Winship, Finlay Macrae, Lior Katz, Ido Laish, Elez Vainer, Kevin Monahan, Elizabeth Half, Karoline Horisberger, Leandro Apolinário da Silva, Vincent Heuveline, Christina Therkildsen, Charlotte Lautrup, Louise L Klarskov, Giulia Martina Cavestro, Gabriela Möslein, Eivind Hovig, Mev Dominguez-Valentin
BACKGROUND: Colorectal cancers (CRCs) in the Lynch syndromes have been assumed to emerge through an accelerated adenoma-carcinoma pathway. In this model adenomas with deficient mismatch repair have an increased probability of acquiring additional cancer driver mutation(s) resulting in more rapid progression to malignancy. If this model was accurate, the success of colonoscopy in preventing CRC would be a function of the intervals between colonoscopies and mean sojourn time of detectable adenomas...
May 13, 2024: Hereditary Cancer in Clinical Practice
https://read.qxmd.com/read/38740654/higher-diversity-of-sulfur-oxidizing-bacteria-based-on-soxb-gene-sequencing-in-surface-water-than-in-spring-in-wudalianchi-volcanic-group-ne-china
#35
JOURNAL ARTICLE
Lirong Geng, Lei Yang, Tao Liu, Shuang Zhang, Xindi Sun, Weidong Wang, Hong Pan, Lei Yan
INTRODUCTION: Sulfur-oxidizing bacteria (SOB) play a key role in the biogeochemical cycling of sulfur. OBJECTIVES: To explore SOB diversity, distribution, and physicochemical drivers in five volcanic lakes and two springs in the Wudalianchi volcanic field, China. METHODS: This study analyzed microbial communities in samples via high-throughput sequencing of the soxB gene. Physical-chemical parameters were measured, and QIIME 2 (v2019...
May 14, 2024: International Microbiology: the Official Journal of the Spanish Society for Microbiology
https://read.qxmd.com/read/38739790/extreme-elevational-migration-spurred-cryptic-speciation-in-giant-hummingbirds
#36
JOURNAL ARTICLE
Jessie L Williamson, Ethan F Gyllenhaal, Selina M Bauernfeind, Emil Bautista, Matthew J Baumann, Chauncey R Gadek, Peter P Marra, Natalia Ricote, Thomas Valqui, Francisco Bozinovic, Nadia D Singh, Christopher C Witt
The ecoevolutionary drivers of species niche expansion or contraction are critical for biodiversity but challenging to infer. Niche expansion may be promoted by local adaptation or constrained by physiological performance trade-offs. For birds, evolutionary shifts in migratory behavior permit the broadening of the climatic niche by expansion into varied, seasonal environments. Broader niches can be short-lived if diversifying selection and geography promote speciation and niche subdivision across climatic gradients...
May 21, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38739716/global-atlas-of-methane-metabolism-marker-genes-in-soil
#37
JOURNAL ARTICLE
Yafei Ou, Zhongda Ren, Xi Chen, Zhenran Jiang, Qiancai Liu, Xiaofei Li, Yanling Zheng, Xia Liang, Min Liu, Lijun Hou, Hongpo Dong
Methane, a greenhouse gas, plays a pivotal role in the global carbon cycle, influencing the Earth's climate. Only a limited number of microorganisms control the flux of biologically produced methane in nature, including methane-oxidizing bacteria, anaerobic methanotrophic archaea, and methanogenic archaea. Although previous studies have revealed the spatial and temporal distribution characteristics of methane-metabolizing microorganisms in local regions by using the marker genes pmoA or mcrA , their biogeographical patterns and environmental drivers remain largely unknown at a global scale...
May 13, 2024: Environmental Science & Technology
https://read.qxmd.com/read/38738976/genomic-landscape-defines-peritoneal-metastatic-pattern-and-related-target-of-peritoneal-metastasis-in-colorectal-cancer
#38
JOURNAL ARTICLE
Minhui Hu, Rui Luo, Keli Yang, Yang Yu, Qiwen Pan, Mingming Yuan, Rongrong Chen, Hui Wang, Qiyuan Qin, Tenghui Ma, Huaiming Wang
The primary objective of this study is to develop a prediction model for peritoneal metastasis (PM) in colorectal cancer by integrating the genomic features of primary colorectal cancer, along with clinicopathological features. Concurrently, we aim to identify potential target implicated in the peritoneal dissemination of colorectal cancer through bioinformatics exploration and experimental validation. By analyzing the genomic landscape of primary colorectal cancer and clinicopathological features from 363 metastatic colorectal cancer patients, we identified 22 differently distributed variables, which were used for subsequent LASSO regression to construct a PM prediction model...
May 13, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38737285/identification-of-methylation-driver-genes-for-predicting-the-prognosis-of-pancreatic-cancer-patients-based-on-whole-genome-dna-methylation-sequencing-technology
#39
JOURNAL ARTICLE
Chao Song, Ganggang Wang, Mengmeng Liu, Zijin Xu, Xin Liang, Kai Ding, Yu Chen, Wenquan Wang, Wenhui Lou, Liang Liu
This study was based on the use of whole-genome DNA methylation sequencing technology to identify DNA methylation biomarkers in tumor tissue that can predict the prognosis of patients with pancreatic cancer (PCa). TCGA database was used to download PCa-related DNA methylation and transcriptome atlas data. Methylation driver genes (MDGs) were obtained using the MethylMix package. Candidate genes in the MDGs were screened for prognostic relevance to PCa patients by univariate Cox analysis, and a prognostic risk score model was constructed based on the key MDGs...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38736501/immunotherapy-for-patients-with-advanced-non-small-cell-lung-cancer-harboring-oncogenic-driver-alterations-other-than-egfr-a-multicenter-real-world-analysis
#40
JOURNAL ARTICLE
Tian Tian, Yanying Li, Juan Li, Hongyu Xu, Hua Fan, Jiang Zhu, Yongsheng Wang, Feng Peng, Youling Gong, Yijia Du, Xiaoyan Yan, Xiulan He, Ayse Ece Cali Daylan, Andreas Pircher, Shane S Neibart, Yusuke Okuma, Min Hee Hong, Meijuan Huang, You Lu
BACKGROUND: The administration of immune checkpoint inhibitors (ICIs) in advanced non-small cell lung cancer (NSCLC) with oncogenic driver alterations other than epidermal growth factor receptor (EGFR) aroused a heated discussion. We thus aimed to evaluate ICI treatment in these patients in real-world routine clinical practice. METHODS: A multicenter, retrospective study was conducted for NSCLC patients with at least one gene alteration ( KRAS, HER2, BRAF, MET, RET, ALK, ROS1 ) receiving ICI monotherapy or combination treatment...
April 29, 2024: Translational Lung Cancer Research
keyword
keyword
110602
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.